Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Medical and surgical technological advances show promise for future glaucoma management.
Clinical pilot study evaluates effect after 1 month of wear.
Dina Erickson, OD, FAAO, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from her talk on glaucoma suspects.
Understand the condition’s structural, innervational, neurological, and genetic abnormalities
The expenditure of embracing new technologies is worthwhile.
Pathogenesis and detection of diabetic retinopathy.
Medical and surgical technological advances show promise for future glaucoma management.
Pediatric TINU syndrome is rare, but responds well to treatment.
Considering recovery time, potential adverse effects, and future eye care needs can increase patient satisfaction.
Specialty care is always needed in any field, and myopia control is no exception.
Educational tools, visual aids can help children with visual impairments thrive.
Alexis G. Malkin, OD, FAAO, and Anita Gulmiri, OD, FAAO, share highlights from their presentation, "Intersection of low vision and contact lens: unique examples of co-management," which they presented during AAOpt 2022.
Technologies that improve treatment of ONHD and similar pathologies.
ODs have the rare opportunity to engage as well as educate patients on hypertension.
Building confidence and knowledge can reduce office visits and increase results.
Harmin Chima, OD, met with Optometry Times to discuss treatment options for ocular surface disease with Biovance's 3-layer amniotic membrane graft.
In this Q&A, John D. Gelles, OD, and Steven Greenstein, MD, chat about what inspired them to launch the symposium, what makes this year’s agenda especially exciting, and why the future of refractive care depends on stronger collaboration between ODs and MDs.
John Samples, MD, shares highlights from his the glaucoma panel discussion during the 2023 Controversies in Modern Eye Care meeting.
These options increase the depth of field to address the symptoms of presbyopia
Shane Swatts, OD, reviewed the key points of his course on intense pulse light therapy.
Following a discussion on low-dose atropine, Paul Karpecki, OD, FAAO, shares his views on what the future of myopia management looks like.
Roundtable of experts discuss impact, management of retinal disease.
Embracing new technology is good for patients and provides protection against malpractice claims.
Nutrition is not ancillary to eye health—it is foundational.
Eyecare practitioners' top misconceptions just may surprise you.
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO, provided their insights during CIME 2025 on May 4.